APLLTD
Alembic Pharmaceuticals Limited
Each stock's 10,000-path forecast, rendered as light.
Alembic Pharmaceuticals Limited (APLLTD) Stock Analysis & Case Study
Is APLLTD a good buy? The data-driven verdict.
Alembic Pharmaceuticals Limited (APLLTD) trades at ₹830,on the numbers it worth a closer look, a Downstox Snapshot Score of 57/100.
On the numbers, Alembic Pharmaceuticals Limited (APLLTD) worth a closer look, a Downstox Snapshot Score of 57/100, weighing fairly valued at 21.9× earnings, ROE of 13.4%, a 56% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
APLLTD fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How APLLTD ranks against the 2,373 companies in our screener
- APLLTD's market cap of 16,317 Cr ranks in the 82nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- APLLTD's book value of ₹289 ranks in the 80th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- APLLTD's promoter holding of 69.9% ranks in the 74th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- APLLTD's 3-year profit (PAT) growth of 28.0% ranks in the 67th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- APLLTD's 3-year revenue growth of 9.0% ranks in the 47th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- APLLTD's debt-to-equity ratio of 0.25x is lower than 57% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is APLLTD overvalued? APLLTD P/E vs peers
APLLTD trades at 21.9× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
APLLTD share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of APLLTD history (3%/yr drift, 33%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| APLLTD 2027 | ₹568 | ₹873 | ₹1,342 | +5% |
| APLLTD 2028 | ₹497 | ₹918 | ₹1,694 | +11% |
| APLLTD 2029 | ₹458 | ₹965 | ₹2,035 | +16% |
| APLLTD 2030 | ₹434 | ₹1,015 | ₹2,373 | +22% |
| APLLTD 2031 | ₹411 | ₹1,067 | ₹2,770 | +29% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability APLLTD goes up, or doubles?
The bull case for APLLTD
- APLLTD's P/E of 21.9x is lower than 59% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- APLLTD's return on equity of 13.4% ranks in the 65th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹2,035.
The bear case & risks
- No model or past record guarantees future returns, treat this as one input, not a decision.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹458.
APLLTD volatility & expected range, how bumpy is the ride?
Over the last 9.8 years APLLTD compounded at 3%/year with annualized volatility of 33%. That volatility implies a 1-year 80% range of ₹568-₹1,342, the honest backbone behind any single price target.
APLLTD price forecast, the full 60-month probability fan
APLLTD price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds APLLTD hits common targets within the simulated horizon?
Full multi-horizon detail on the APLLTD price target & forecast page.
APLLTD Piotroski F-Score: 6/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. APLLTD scores 6/8, mixed financial health.
APLLTD MTF margin & leverage across 11 brokers
Margin Trading Facility lets you buy APLLTD with part of the capital. Lower margin % = higher leverage. Rates compared across 11 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.00% | 2.9× |
| ZerodhaCHEAPEST | 29.87% | 3.3× |
| Groww | 29.98% | 3.3× |
| Dhan | 30.00% | 3.3× |
| Kotak Neo | 34.97% | 2.9× |
| Paytm Money | 30.69% | 3.3× |
| Pocketful | 30.15% | 3.3× |
| Fyers | 31.25% | 3.2× |
| Anand RathiCHEAPEST | 29.87% | 3.3× |
| Bajaj Broking | 34.00% | 2.9× |
| Share India | 29.96% | 3.3× |
Compare every broker on the APLLTD MTF page.
About Alembic Pharmaceuticals Limited: sector, index & market-cap context
Alembic Pharmaceuticals Limited (APLLTD) is a small-cap NSE-listed company, with a market capitalisation of ₹16,317 Cr. See more stocks on our screener.
How the APLLTD Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Alembic Pharmaceuticals Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
APLLTD analysis, FAQs
Is Alembic Pharmaceuticals Limited (APLLTD) a good buy?
On the numbers, Alembic Pharmaceuticals Limited (APLLTD) worth a closer look, a Downstox Snapshot Score of 57/100, weighing fairly valued at 21.9× earnings, ROE of 13.4%, a 56% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is APLLTD overvalued or undervalued?
APLLTD trades at 21.9× earnings, fairly valued versus the ~22× long-run Nifty average.
What is the APLLTD share price target for 2031?
APLLTD's probability-weighted 2031 median target is ₹1,067, with an 80% range of ₹411-₹2,770 (10,000-path Monte-Carlo).
What is the probability APLLTD doubles in 5 years?
The modelled probability of APLLTD reaching ₹1,660 (2×) within 5 years is 28%.
What is the bull case for APLLTD?
APLLTD's P/E of 21.9x is lower than 59% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. APLLTD's return on equity of 13.4% ranks in the 65th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
What are the risks in APLLTD?
No model or past record guarantees future returns, treat this as one input, not a decision.